Title: Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform.
Journal: Toxicology20170615
Title: Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery.
Journal: Journal of chemotherapy (Florence, Italy)20120201
Title: Semen quality in patients with Chlamydia trachomatis genital infection treated concurrently with prulifloxacin and a phytotherapeutic agent.
Journal: Journal of andrology20120101
Title: Prulifloxacin versus levofloxacin in the treatment of respiratory and urinary tract infections: a multicentre, double-blind, randomized controlled clinical trial.
Journal: Chemotherapy20120101
Title: Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study.
Journal: Biomedical chromatography : BMC20110801
Title: Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.
Journal: Medical mycology20110501
Title: Prulifloxacin: a review focusing on its use beyond respiratory and urinary tract infections.
Journal: International journal of antimicrobial agents20110401
Title: (99m)Tc-prulifloxacin in artificially infected animals. Radiosynthesis and biological evaluation.
Journal: Nuklearmedizin. Nuclear medicine20110101
Title: [Susceptibility surveillance of clinical isolates to fluoroquinolone antimicrobial agents from 2003 to 2008: post-marketing study of prulifloxacin].
Journal: The Japanese journal of antibiotics20100601
Title: Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.
Journal: Clinical drug investigation20100101
Title: In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Journal: BMC microbiology20100101
Title: Prulifloxacin ECG study.
Journal: Clinical drug investigation20100101
Title: Re: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
Journal: International journal of antimicrobial agents20090901
Title: Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study.
Journal: International journal of antimicrobial agents20090601
Title: Prulifloxacin as a trigger of myasthenia gravis.
Journal: Journal of the neurological sciences20090515
Title: Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
Journal: Future microbiology20090201
Title: Penetration of orally administered prulifloxacin into human prostate tissue.
Journal: Clinical drug investigation20090101
Title: Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Journal: Drug metabolism and pharmacokinetics20090101
Title: Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase.
Journal: Chemotherapy20090101
Title: Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20080901
Title: Capillary electrophoresis-chemiluminescence determination of norfloxacin and prulifloxacin.
Journal: Analytica chimica acta20080815
Title: Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography.
Journal: Journal of pharmaceutical and biomedical analysis20080715
Title: Determination of adenosine disodium triphosphate using prulifloxacin-terbium(III) as a fluorescence probe by spectrofluorimetry.
Journal: Analytica chimica acta20080310
Title: Highly sensitive spectrofluorimetric determination of trace amounts of prulifloxacin using the aluminium(III)-prulifloxacin system.
Journal: Luminescence : the journal of biological and chemical luminescence20080101
Title: Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
Journal: Drug metabolism and pharmacokinetics20071001
Title: Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy20071001
Title: Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: an in vitro study.
Journal: European journal of medicinal chemistry20070701
Title: In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
Journal: International journal of antimicrobial agents20070601
Title: Prulifloxacin versus levofloxacin in the treatment of chronic bacterial prostatitis: a prospective, randomized, double-blind trial.
Journal: Journal of chemotherapy (Florence, Italy)20070601
Title: Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.
Journal: International journal of chronic obstructive pulmonary disease20070301
Title: Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrations.
Journal: Drugs in R&D20070101
Title: Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20060307
Title: [In vitro activity of prulifloxacin, levofloxacin and ciprofloxacin against urinary pathogens].
Journal: Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive20060301
Title: Prulifloxacin: a new antibacterial fluoroquinolone.
Journal: Expert review of anti-infective therapy20060201
Title: Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
Journal: Pulmonary pharmacology & therapeutics20060101
Title: Pharmacologic characteristics of prulifloxacin.
Journal: Pulmonary pharmacology & therapeutics20060101
Title: Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
Journal: International journal of antimicrobial agents20051101
Title: Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin.
Journal: Journal of chemotherapy (Florence, Italy)20050401
Title: Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
Journal: Urologia internationalis20050101
Title: Penetration of orally administered prulifloxacin into human lung tissue.
Journal: Clinical pharmacokinetics20050101
Title: Prulifloxacin.
Journal: Drugs20040101
Title: Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.
Journal: European journal of pharmacology20030905
Title: Involvement of multiple transport systems in the disposition of an active metabolite of a prodrug-type new quinolone antibiotic, prulifloxacin.
Journal: Drug metabolism and pharmacokinetics20030101
Title: [In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
Journal: The Japanese journal of antibiotics20021201
Title: [In vitro short-term bactericidal activity and accumulation of NM394, the active metabolite of prulifloxacin, for Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa: comparison with ciprofloxacin, levofloxacin, and gatifloxacin].
Journal: The Japanese journal of antibiotics20021201
Title: [Inhibitory activity of NM394, the active form of prodrug prulifloxacin against type II topoisomerase from Pseudomonas aeruginosa].
Journal: The Japanese journal of antibiotics20021201
Title: Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Journal: Respiration; international review of thoracic diseases20020101
Title: Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Journal: Arzneimittel-Forschung19961201
Title: M Ozaki, et al. In vivo evaluation of NM441, a new thiazeto-quinoline derivative. Antimicrob Agents Chemother. 1991 Dec;35(12):2496-9.
Title: Guillem Prats, et al. Prulifloxacin: a new antibacterial fluoroquinolone. Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41.
